Taro Pharmaceutical
TARO
$36.51
Share price
-0.63%
Change (1 day)
24.31%
Change (1 year)
Categories
Revenue for Taro Pharmaceutical (TARO)
Revenue in 2023 (TTM): $0.58 B
According to Taro Pharmaceutical's latest financial reports the company's current revenue (TTM) is $0.58 B. In 2021 the company made a revenue of $0.56 B a decrease over the years 2020 revenue that were of $0.57 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Taro Pharmaceutical from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.58 B | |
| 2021 | $0.56 B | -1.59% |
| 2020 | $0.57 B | -11.42% |
| 2019 | $0.64 B | -2.32% |
| 2018 | $0.66 B | -2.62% |
| 2017 | $0.68 B | -27.95% |
| 2016 | $0.94 B | 1.96% |
| 2015 | $0.92 B | 15.38% |
| 2014 | $0.80 B | 9.32% |
| 2013 | $0.73 B | 13.25% |
| 2012 | $0.65 B | 28.73% |
| 2011 | $0.50 B | 28.91% |
| 2010 | $0.39 B | 9.68% |
| 2009 | $0.35 B | |
| 2005 | $0.30 B | 6.32% |
| 2004 | $0.28 B | -9.93% |
| 2003 | $0.31 B | 49.1% |
| 2002 | $0.21 B | 40.93% |
| 2001 | $0.15 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $91.32 B | 15,532.48% | 🇺🇸 USA |
 Novartis NVS | $52.32 B | 8,856.64% | 🇨🇭 Switzerland |
 Pfizer PFE | $68.53 B | 11,632.32% | 🇺🇸 USA |
 Merck MRK | $59.31 B | 10,053.36% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $36.53 B | 6,154.71% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $15.27 B | 2,514.43% | 🇮🇱 Israel |